ClearPoint Neuro, Inc. (CLPT)
USD 11.31
(-6.8%)
USD 11.31
(-6.8%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -9.19 Million USD | 41.14% |
| 2022 | -15.62 Million USD | 62.63% |
| 2021 | -41.82 Million USD | -1109.53% |
| 2020 | 4.14 Million USD | 228.15% |
| 2019 | -3.23 Million USD | -951.88% |
| 2018 | 379.5 Thousand USD | 108.68% |
| 2017 | -4.37 Million USD | -471.75% |
| 2016 | 1.17 Million USD | -56.51% |
| 2015 | 2.7 Million USD | 274.1% |
| 2014 | -1.55 Million USD | -131.66% |
| 2013 | 4.9 Million USD | -0.15% |
| 2012 | 4.91 Million USD | -32.78% |
| 2011 | 7.31 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -19.04 Million USD | 11.21% |
| 2024 Q1 | -21.45 Million USD | -133.22% |
| 2023 Q4 | -9.19 Million USD | 10.93% |
| 2023 Q3 | -10.32 Million USD | 15.31% |
| 2023 FY | -9.19 Million USD | 41.14% |
| 2023 Q2 | -12.19 Million USD | -22.83% |
| 2023 Q1 | -9.92 Million USD | 36.48% |
| 2022 Q3 | -6.76 Million USD | 40.98% |
| 2022 Q4 | -15.62 Million USD | -131.16% |
| 2022 FY | -15.62 Million USD | 62.63% |
| 2022 Q1 | -37.48 Million USD | 10.39% |
| 2022 Q2 | -11.45 Million USD | 69.43% |
| 2021 Q3 | -37.48 Million USD | 9.37% |
| 2021 Q4 | -41.82 Million USD | -11.59% |
| 2021 Q1 | -37.58 Million USD | -1007.22% |
| 2021 Q2 | -41.35 Million USD | -10.03% |
| 2021 FY | -41.82 Million USD | -1109.53% |
| 2020 Q1 | 169.58 Thousand USD | 105.25% |
| 2020 Q2 | 2.01 Million USD | 1089.16% |
| 2020 Q3 | 3.39 Million USD | 68.26% |
| 2020 Q4 | 4.14 Million USD | 22.1% |
| 2020 FY | 4.14 Million USD | 228.15% |
| 2019 FY | -3.23 Million USD | -951.88% |
| 2019 Q1 | 1.62 Million USD | 329.33% |
| 2019 Q3 | -3.95 Million USD | 23.16% |
| 2019 Q2 | -5.14 Million USD | -415.86% |
| 2019 Q4 | -3.23 Million USD | 18.25% |
| 2018 Q2 | -1.5 Million USD | 38.74% |
| 2018 FY | 379.5 Thousand USD | 108.68% |
| 2018 Q4 | 379.5 Thousand USD | 198.95% |
| 2018 Q3 | -383.54 Thousand USD | 74.54% |
| 2018 Q1 | -2.45 Million USD | 43.75% |
| 2017 Q4 | -4.37 Million USD | 29.89% |
| 2017 Q1 | 2.62 Million USD | 123.03% |
| 2017 Q3 | -6.23 Million USD | 22.52% |
| 2017 Q2 | -8.04 Million USD | -406.83% |
| 2017 FY | -4.37 Million USD | -471.75% |
| 2016 Q2 | 4.03 Million USD | -10.63% |
| 2016 Q4 | 1.17 Million USD | 2894.5% |
| 2016 FY | 1.17 Million USD | -56.51% |
| 2016 Q1 | 4.51 Million USD | 67.0% |
| 2016 Q3 | -42.08 Thousand USD | -101.04% |
| 2015 Q2 | 4.37 Million USD | 223.73% |
| 2015 Q3 | 6.14 Million USD | 40.6% |
| 2015 FY | 2.7 Million USD | 274.1% |
| 2015 Q4 | 2.7 Million USD | -55.99% |
| 2015 Q1 | 1.35 Million USD | 186.91% |
| 2014 FY | -1.55 Million USD | -131.66% |
| 2014 Q1 | 1.65 Million USD | -66.34% |
| 2014 Q2 | 3.45 Million USD | 108.93% |
| 2014 Q3 | 5.71 Million USD | 65.5% |
| 2014 Q4 | -1.55 Million USD | -127.2% |
| 2013 Q3 | -995.29 Thousand USD | -173.43% |
| 2013 Q2 | 1.35 Million USD | 249.59% |
| 2013 Q1 | -906.12 Thousand USD | -118.44% |
| 2013 FY | 4.9 Million USD | -0.15% |
| 2013 Q4 | 4.9 Million USD | 593.01% |
| 2012 Q3 | 2.74 Million USD | -48.33% |
| 2012 Q4 | 4.91 Million USD | 79.19% |
| 2012 Q2 | 5.3 Million USD | 1568.52% |
| 2012 Q1 | 318.11 Thousand USD | -95.65% |
| 2012 FY | 4.91 Million USD | -32.78% |
| 2011 FY | 7.31 Million USD | 0.0% |
| 2011 Q4 | 7.31 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 133.967% |
| BrainsWay Ltd. | -10.32 Million USD | 10.862% |
| Cerus Corporation | 84.35 Million USD | 110.905% |
| Envoy Medical, Inc. | -3.81 Million USD | -141.19% |
| electroCore, Inc. | -9.95 Million USD | 7.594% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | -79.493% |
| IceCure Medical Ltd | -9.93 Million USD | 7.399% |
| Inogen, Inc. | -103.56 Million USD | 91.118% |
| OrthoPediatrics Corp. | -9.26 Million USD | 0.734% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -152.65% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 29.763% |
| MaxCyte, Inc. | -27.76 Million USD | 66.866% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | -79.035% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -1497.695% |
| Orthofix Medical Inc. | 96.44 Million USD | 109.538% |
| PAVmed Inc | 29.08 Million USD | 131.627% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 45.693% |
| RxSight, Inc. | -6.68 Million USD | -37.71% |
| Sight Sciences, Inc. | -102.71 Million USD | 91.044% |
| SI-BONE, Inc. | 5.72 Million USD | 260.794% |
| TELA Bio, Inc. | -3.94 Million USD | -132.945% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 116.048% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 2713.352% |
| Acutus Medical, Inc. | 12.27 Million USD | 174.917% |
| Talis Biomedical Corporation | -57.06 Million USD | 83.88% |
| Spectral AI, Inc. | -3.5 Million USD | -162.753% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 80.846% |
| CVRx, Inc. | -59.95 Million USD | 84.657% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 563.625% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 820.001% |
| Bioventus Inc. | 372.51 Million USD | 102.469% |
| Venus Concept Inc. | 74.3 Million USD | 112.381% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 9.654% |
| LivaNova PLC | 62.53 Million USD | 114.711% |
| 908 Devices Inc. | -115.09 Million USD | 92.008% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 102.868% |
| Nemaura Medical Inc. | 9.92 Million USD | 192.685% |
| NeuroPace, Inc. | 54.33 Million USD | 116.93% |
| LENSAR, Inc. | -18.31 Million USD | 49.765% |
| Apyx Medical Corporation | -5.15 Million USD | -78.587% |
| Cutera, Inc. | 288.3 Million USD | 103.191% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 222.409% |
| BioSig Technologies, Inc. | 262 Thousand USD | 3611.069% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 79.012% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.655% |
| Axonics, Inc. | -77.19 Million USD | 88.083% |
| Outset Medical, Inc. | 67.67 Million USD | 113.592% |
| IRIDEX Corporation | -4.28 Million USD | -114.529% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 94.833% |
| IRadimed Corporation | -47.71 Million USD | 80.723% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -203.999% |
| INVO Bioscience, Inc. | 8.45 Million USD | 208.849% |
| Telesis Bio, Inc. | 32.63 Million USD | 128.188% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -267.646% |
| Varex Imaging Corporation | 316.9 Million USD | 102.903% |
| Quipt Home Medical Corp. | 81.73 Million USD | 111.255% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -230.661% |
| Pulmonx Corporation | -42.36 Million USD | 78.284% |
| Dynatronics Corporation | 6.2 Million USD | 248.275% |
| Modular Medical, Inc. | -8.04 Million USD | -14.387% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -114.08% |
| Semler Scientific, Inc. | -57.13 Million USD | 83.898% |
| InMode Ltd. | -135.39 Million USD | 93.206% |
| Bruker Corporation | 891.3 Million USD | 101.032% |
| Cytosorbents Corporation | 4.18 Million USD | 319.966% |
| DexCom, Inc. | 2.02 Billion USD | 100.454% |
| Align Technology, Inc. | -840.47 Million USD | 98.905% |
| Viveve Medical, Inc. | -13.81 Million USD | 33.403% |
| ZimVie Inc. | 450.41 Million USD | 102.042% |
| Movano Inc. | -5.86 Million USD | -56.819% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 93.158% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -1497.695% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 563.625% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 102.578% |
| Profound Medical Corp. | -18.17 Million USD | 49.396% |
| Insulet Corporation | 798.1 Million USD | 101.153% |
| enVVeno Medical Corporation | -2.21 Million USD | -314.743% |
| Surmodics, Inc. | -12.01 Million USD | 23.431% |
| iCAD, Inc. | -21.2 Million USD | 56.627% |
| Nuwellis, Inc. | -2.81 Million USD | -226.321% |
| Biotricity, Inc. | 23.09 Million USD | 139.835% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 109.823% |
| Aethlon Medical, Inc. | -4.5 Million USD | -104.347% |
| InspireMD, Inc. | -8.04 Million USD | -14.344% |
| PAVmed Inc. | 29.08 Million USD | 131.627% |
| BIOLASE, Inc. | 11.34 Million USD | 181.091% |
| Beyond Air, Inc. | 6.22 Million USD | 247.68% |
| FONAR Corporation | -14.66 Million USD | 37.274% |
| AxoGen, Inc. | 32.26 Million USD | 128.51% |
| Vivani Medical, Inc. | 42 Thousand USD | 22002.381% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 13.689% |
| Inari Medical, Inc. | -7.16 Million USD | -28.46% |
| UFP Technologies, Inc. | 40.77 Million USD | 122.561% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 399.776% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -92.798% |
| Tenon Medical, Inc. | -1.25 Million USD | -632.988% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | -20.944% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 22.868% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.415% |
| Sintx Technologies, Inc. | 905 Thousand USD | 1116.464% |
| NanoVibronix, Inc. | -3.27 Million USD | -180.628% |
| Quanterix Corporation | -132.95 Million USD | 93.081% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -230.661% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 58.869% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 101.22% |
| TransMedics Group, Inc. | 121.13 Million USD | 107.594% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 64.862% |
| NeuroMetrix, Inc. | -1.49 Million USD | -516.94% |
| Hyperfine, Inc. | -75.61 Million USD | 87.835% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 106.044% |
| Biomerica, Inc. | -3.38 Million USD | -171.758% |
| Bone Biologics Corporation | -3.02 Million USD | -203.942% |
| AVITA Medical, Inc. | -26.23 Million USD | 64.932% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -400.378% |
| Silk Road Medical, Inc | 64.42 Million USD | 114.279% |